Ritonavir Oral Capsule

Brand(s)
Norvir
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Abbvie Inc. (2015-03-31)
Oldest Current Product
2010-05-06
License(s)
NDA
RxNORM
ORAL CAPSULE\RITONAVIR
FDAOB
ORAL\CAPSULE\RITONAVIR
SPL Active
ORAL\CAPSULE\RITONAVIR
SPL Moiety
ORAL\CAPSULE\RITONAVIR

product(s) by strength(s)

ritonavir 100 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000746633NorvirNDAAbbvie Inc.2010-05-06RITONAVIRORALCAPSULENDA02094513b059c6-0c6c-49a5-b985-a4b05caf9ac9

application(s)

#idtitledeprecatedapplicantapprovedpatentapproved drug
1NDA020680NORVIRTrueABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV1996-03-01p5648497NDA020680_001
2NDA020945NORVIRABBVIE INC1999-06-29p6232333
p6037157, TREATMENT OF HIV INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS
p6703403, TREATMENT OF HIV IN CONCOMITANT THERAPY
p5648497
p7141593, SUBSTANCE
p7432294, SUBSTANCE
NDA020945_001

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapprovedapplication
1NDA020680_001discontinuedRITONAVIR (100MG)ORALCAPSULEFalse1996-03-01NORVIR
2NDA020945_001RXRITONAVIR (100MG)ORALCAPSULETrue1999-06-29NORVIR

patent(s)

#idexpiration dateapplication(s)in other drug docs
1p5648497 (view patent)2014-07-15NDA020680, NDA020945, NDA020659, NDA021226, NDA021251, NDA021906, NDA022417lopinavir / Ritonavir Oral Solution
lopinavir / Ritonavir Oral Tablet
Ritonavir Oral Tablet
Ritonavir Oral Solution
2p6037157 (view patent)2016-06-26NDA020945, NDA020659, NDA021226, NDA021251, NDA021906, NDA021976, NDA022417, NDA202895, NDA206619, NDA207931lopinavir / Ritonavir Oral Solution
darunavir Oral Suspension
ombitasvir / paritaprevir / Ritonavir Oral Tablet
darunavir Oral Tablet
lopinavir / Ritonavir Oral Tablet
Ritonavir Oral Tablet
Ritonavir Oral Solution
3p6232333 (view patent)2017-11-07NDA020945, NDA021226
4p6703403 (view patent)2016-06-26NDA020945, NDA020659, NDA021226, NDA021251, NDA021906, NDA021976, NDA022417, NDA202895, NDA206619, NDA207931lopinavir / Ritonavir Oral Solution
darunavir Oral Suspension
ombitasvir / paritaprevir / Ritonavir Oral Tablet
darunavir Oral Tablet
lopinavir / Ritonavir Oral Tablet
Ritonavir Oral Tablet
Ritonavir Oral Solution
5p7141593 (view patent)2020-05-22NDA020945, NDA021226
6p7432294 (view patent)2020-05-22NDA020945, NDA021226

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
113b059c6-0c6c-49a5-b985-a4b05caf9ac9 (view SPL)These highlights do not include all the information needed to use NORVIR safely and effectively. See full prescribing information for NORVIR. NORVIR (ritonavir) capsules, soft gelatin for oral useInitial U.S. Approval: 1996prescriptionHuman PrescriptionAbbvie Inc.2015-03-311492000746633

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII